N-terminal pro-B-type natriuretic peptide (NT–pro-BNP) is related to stress-induced
myocardial ischemia and/or volume overload, both common in patients with renal dysfunction.
This might compromise the prognostic usefulness of NT–pro-BNP in patients with renal
impairment before vascular surgery. We assessed the prognostic value of NT–pro-BNP
in the entire strata of renal function. In 356 patients (median age 69 years, 77%
men), cardiac history, glomerular filtration rate (GFR, ml/min/1.73 m2), and NT–pro-BNP level (pg/ml) were assessed preoperatively. Troponin T and electrocardiography
were assessed postoperatively on days 1, 3, 7, and 30. The end point was the composite
of cardiovascular death, Q-wave myocardial infarction, and troponin T release. Multivariate
analysis was used to evaluate the interaction between GFR, NT–pro-BNP and their association
with postoperative outcome. Median GFR was 78 ml/min/1.73 m2 and the median concentration of NT–pro-BNP was 197 pg/ml. The end point was reached
in 64 patients (18%); cardiac death occurred in 7 (2.0%), Q-wave myocardial infarction
in 34 (9.6%), and non–Q-wave myocardial infarction in 23 (6.5%). After adjustment
for confounders, NT–pro-BNP levels and GFR remained significantly associated with
the end point (p = 0.005). The prognostic value of NT–pro-BNP was most pronounced
in patients with GFR ≥90 (odds ratio [OR] 1.18, 95% confidence interval [CI] 0.80
to 1.76) compared with patients with GFR 60 to 89 (OR 1.04, 95% CI 1.002 to 1.07),
and with GFR 30 to 59 (OR 1.12, 95% CI 1.03 to 1.21). In patients with GFR <30 ml/min/1.73
m2, NT–pro-BNP levels have no prognostic value (OR 1.00, 95% CI 0.99 to 1.01). In conclusion,
the discriminative value of NT–pro-BNP is most pronounced in patients with GFR ≥90
ml/min/1.73 m2 and has no prognostic value in patients with GFR <30 ml/min/1.73 m2.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to American Journal of CardiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Assessment of cardiac risk before non-cardiac surgery: brain natriuretic peptide in 1590 patients.Heart. 2006; 92: 1645-1650
- Myocardial infarction redefined; a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.J Am Coll Cardiol. 2000; 36: 959-969
- National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification.Ann Intern Med. 2003; 139: 137-147
- Predictive performance of the modification of diet in renal disease and Cockcroft-Gault equations for estimating renal function.J Am Soc Nephrol. 2005; 16: 763-773
- Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO).Kidney Int. 2005; 67: 2089-2100
- Cardiac natriuretic peptides: new laboratory parameters in heart failure patients.Clin Lab. 2001; 47: 265-277
- Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man.J Clin Endocrinol Metab. 1993; 76: 91-96
- N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy.Circulation. 2003; 108: 275-281
- Diagnostic and prognostic value of plasma brain natriuretic peptide in non–dialysis-dependent CRF.Am J Kidney Dis. 2004; 44: 420-428
- Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study.J Am Coll Cardiol. 2006; 47: 91-97
- N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide for identifying coronary artery disease and left ventricular hypertrophy in ambulatory chronic kidney disease patients.Am J Cardiol. 2006; 97: 1530-1534
- Association of cardiac troponin, CK-MB, and postoperative myocardial ischemia with long-term survival after major vascular surgery.J Am Coll Cardiol. 2003; 42: 1547-1554
- Ability of troponins to predict adverse outcomes in patients with renal insufficiency and suspected acute coronary syndromes: a case-matched study.J Am Coll Cardiol. 1999; 33: 471-478
- Prognostic usefulness of marginal troponin T elevation.Am J Cardiol. 2004; 93: 275-279
- Impact of glomerular filtration rate on minor troponin T elevations for risk assessment in patients undergoing operation for abdominal aortic aneurysm or lower extremity arterial obstruction.Am J Cardiol. 2006; 98: 1515-1518
Article info
Publication history
Accepted:
July 13,
2007
Received in revised form:
July 13,
2007
Received:
May 9,
2007
Identification
Copyright
© 2008 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
